Efficacy and safety of infigratinib in locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma patients with FGFR2 gene amplification

被引：1
|
作者：
Yuan, J. [1 ]
Shen, L. [1 ]
Liu, T. [2 ]
Xu, H. [3 ]
Yang, J. [4 ]
Wei, J. [5 ]
Jiang, H. [6 ]
Deng, Y. [7 ]
Wang, Y. [8 ]
Zhang, X. [1 ]
Gong, J. [1 ]
Lyu, C. [9 ]
Li, Y. [9 ]
Song, L. [9 ]
机构：
[1] Peking Univ Canc Hosp & Inst, GI Oncol Dept, Beijing, Peoples R China
[2] Fudan Univ, Med Oncol Dept, Zhongshan Hosp, Shanghai, Peoples R China
[3] Hubei Canc Hosp, Oncol Dept, Wuhan, Peoples R China
[4] Fujian Prov Canc Hosp, Clin Oncol, Fuzhou, Fujian, Peoples R China
[5] Nanjing Univ, Oncol Dept, Affiliated Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China
[6] Zhejiang Univ, Dept Med, Affiliated Hosp 1, Med Sch, Hangzhou, Peoples R China
[7] Sun Yat Sen Univ, Affiliated Hosp 6, Clin Oncol, Guangzhou, Guangdong, Peoples R China
[8] Shanxi Canc Hosp, Gastroenterol Ward One Dept, Taiyuan, Peoples R China
[9] LianBio Dev Co Ltd, COTD, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1527P
引用
收藏
页码：S859 / S860
页数：2
相关论文
共 50 条
  • [1] PHARMACOKIN ETICS OF INFIGRATINIB AND ITS ACTIVE METABOLITES IN PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA HARBORING FGFR2 GENE AMPLIFICATIONS.
    Yuan, J.
    Shen, L.
    Liu, T.
    Xu, H.
    Yang, J.
    Wei, J.
    Jiang, H.
    Deng, Y.
    Wang, Y.
    Zhang, X.
    Gong, J.
    Lyu, C.
    Zhang, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S93 - S93
  • [2] Infigratinib for the Treatment of Metastatic or Locally Advanced Cholangiocarcinoma With Known FGFR2 Gene Fusions or Rearrangements
    White, Kathryn
    Anwar, Ahmed I.
    Jin, Kevin
    Bollich, Victoria
    Kelkar, Rucha A.
    Talbot, Norris C.
    Klapper, Rachel J.
    Ahmadzadeh, Shahab
    Viswanath, Omar
    Varrassi, Giustino
    Shekoohi, Sahar
    Kaye, Alan D.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [3] Tumor MET Expression and Gene Amplification in Chinese Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
    Peng, Zhi
    Li, Zhongwu
    Gao, Jing
    Lu, Ming
    Gong, Jifang
    Tang, En-Tzu
    Oliner, Kelly S.
    Hei, Yong-Jiang
    Zhou, Hui
    Shen, Lin
    [J]. MOLECULAR CANCER THERAPEUTICS, 2015, 14 (11) : 2634 - 2641
  • [4] Phase 2 study of futibatinib in patients with specific FGFR aberrations: Activity in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplification
    Satoh, T.
    Barthelemy, P.
    Nogova, L.
    Honda, K.
    Iwasa, S.
    Lee, K.
    Rha, S.
    Ajani, J.
    Hangai, N.
    Liu, S.
    Kremer, J.
    Mina, M.
    Shitara, K.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S165 - S166
  • [5] The prognostic impact of FGFR2 gene amplification in patients receiving fluoropyrimidine and platinum (FP) chemotherapy for with metastatic and locally advanced gastric cancers
    Seo, S.
    Park, S. J.
    Park, S. R.
    Ryu, M. H.
    Ryoo, B. Y.
    Park, Y. S.
    Na, Y. S.
    Lee, C. W.
    Lee, J. K.
    Kang, Y. K.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S472 - S472
  • [6] Frequency of FGFR2 gene amplification in gastric cancer
    Matsumoto, Kazuko
    Arao, Tokuzo
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    Kato, Ken
    Oda, Ichiro
    Taniguchi, Hirokazu
    Koizumi, Fumiaki
    Yanagihara, Kazuyoshi
    Sasaki, Hiroki
    Yamada, Yasuhide
    Nishio, Kazuto
    [J]. CANCER RESEARCH, 2012, 72
  • [7] Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance
    Shoji, Hirokazu
    Yamada, Yasuhide
    Okita, Natsuko
    Takashima, Atsuo
    Honma, Yoshitaka
    Iwasa, Satoru
    Kato, Ken
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    [J]. ANTICANCER RESEARCH, 2015, 35 (09) : 5055 - 5061
  • [8] FGFR2 gene amplification and clinicopathological features in gastric cancer
    Matsumoto, K.
    Arao, T.
    Hamaguchi, T.
    Shimada, Y.
    Kato, K.
    Oda, I.
    Taniguchi, H.
    Koizumi, F.
    Yanagihara, K.
    Sasaki, H.
    Nishio, K.
    Yamada, Y.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (04) : 727 - 732
  • [9] FGFR2 gene amplification and clinicopathological features in gastric cancer
    K Matsumoto
    T Arao
    T Hamaguchi
    Y Shimada
    K Kato
    I Oda
    H Taniguchi
    F Koizumi
    K Yanagihara
    H Sasaki
    K Nishio
    Y Yamada
    [J]. British Journal of Cancer, 2012, 106 : 727 - 732
  • [10] Impact on work productivity in unresectable locally advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma patients and their caregivers
    Xiao, H.
    Hall, J. P.
    Khela, K.
    Moon, R.
    Bertwistle, D.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S904 - S904
12345